Liperoti, Rosa
 Distribuzione geografica
Continente #
NA - Nord America 3.172
EU - Europa 2.912
AS - Asia 2.731
SA - Sud America 576
AF - Africa 75
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 6
Totale 9.478
Nazione #
US - Stati Uniti d'America 3.076
SG - Singapore 1.361
DE - Germania 918
CN - Cina 747
BR - Brasile 478
SE - Svezia 475
IT - Italia 344
UA - Ucraina 277
FR - Francia 215
IE - Irlanda 174
GB - Regno Unito 138
VN - Vietnam 122
IN - India 102
FI - Finlandia 99
ID - Indonesia 99
RU - Federazione Russa 71
TR - Turchia 56
PL - Polonia 52
CA - Canada 51
AR - Argentina 49
HK - Hong Kong 41
MX - Messico 32
BD - Bangladesh 30
JP - Giappone 30
KR - Corea 30
NL - Olanda 29
AT - Austria 28
IQ - Iraq 27
BE - Belgio 25
ZA - Sudafrica 22
ES - Italia 17
CH - Svizzera 16
CI - Costa d'Avorio 15
EC - Ecuador 15
IR - Iran 13
UZ - Uzbekistan 10
CL - Cile 9
TW - Taiwan 9
CO - Colombia 8
EG - Egitto 8
MA - Marocco 8
PK - Pakistan 8
JO - Giordania 7
SA - Arabia Saudita 7
AE - Emirati Arabi Uniti 6
UY - Uruguay 6
CZ - Repubblica Ceca 5
KZ - Kazakistan 5
PT - Portogallo 5
VE - Venezuela 5
KE - Kenya 4
NI - Nicaragua 4
RO - Romania 4
TN - Tunisia 4
AU - Australia 3
DZ - Algeria 3
GA - Gabon 3
HR - Croazia 3
KG - Kirghizistan 3
LT - Lituania 3
NZ - Nuova Zelanda 3
PY - Paraguay 3
TT - Trinidad e Tobago 3
A1 - Anonimo 2
A2 - ???statistics.table.value.countryCode.A2??? 2
AZ - Azerbaigian 2
BB - Barbados 2
CY - Cipro 2
ET - Etiopia 2
GE - Georgia 2
GR - Grecia 2
HN - Honduras 2
IL - Israele 2
LU - Lussemburgo 2
LV - Lettonia 2
MW - Malawi 2
PH - Filippine 2
SN - Senegal 2
AL - Albania 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
BY - Bielorussia 1
CR - Costa Rica 1
DK - Danimarca 1
EU - Europa 1
GI - Gibilterra 1
HU - Ungheria 1
JM - Giamaica 1
KH - Cambogia 1
KW - Kuwait 1
MD - Moldavia 1
ML - Mali 1
MN - Mongolia 1
NG - Nigeria 1
OM - Oman 1
PE - Perù 1
PS - Palestinian Territory 1
SK - Slovacchia (Repubblica Slovacca) 1
SR - Suriname 1
Totale 9.475
Città #
Singapore 647
Chandler 473
Ashburn 366
Dublin 154
Jacksonville 154
Beijing 134
San Mateo 127
Nanjing 97
Jakarta 94
New York 87
Hefei 76
Wilmington 75
Ann Arbor 72
Los Angeles 69
Milan 67
Dearborn 64
Boston 63
Munich 61
Rome 57
The Dalles 55
Nürnberg 52
Lawrence 49
Houston 48
Redwood City 47
Cattolica 46
Moscow 43
Ho Chi Minh City 42
Frankfurt am Main 41
Hong Kong 40
Hangzhou 37
Nanchang 35
Seattle 35
São Paulo 35
Woodbridge 35
Marseille 34
Izmir 33
Boardman 28
Hanoi 28
Chicago 26
Princeton 25
Warsaw 25
Helsinki 24
Brussels 23
Seoul 23
Bremen 22
Buffalo 22
Nuremberg 21
Augusta 19
Brooklyn 19
Hebei 19
Kent 19
Kraków 19
Fairfield 18
London 18
Shenyang 18
Tianjin 18
Vienna 18
Johannesburg 17
Mountain View 17
Santa Clara 17
Menlo Park 16
Trieste 16
Lappeenranta 15
Rio de Janeiro 15
Abidjan 14
Dallas 14
Norwalk 14
Stockholm 14
Tokyo 14
Belo Horizonte 13
Cambridge 13
Fremont 13
Jiaxing 13
North Bergen 13
Atlanta 12
Baghdad 12
Leawood 11
University Park 11
Chennai 10
Guangzhou 10
Redmond 10
Andover 9
Brasília 9
Denver 9
Detroit 9
Düsseldorf 9
Kunming 9
Torino 9
Turku 9
Ankara 8
Curitiba 8
Dhaka 8
Phoenix 8
Pune 8
Tashkent 8
Amman 7
Bexley 7
Campinas 7
Changsha 7
Edmonton 7
Totale 4.575
Nome #
Sarcopenia and mortality among older nursing home residents 248
Disability, More than multimorbidity, was predictive of mortality among older persons aged 80 years and older. 180
Prevalence and risk factors of sarcopenia among nursing home older residents 178
Assessment of neurological manifestations in hospitalized patients with COVID-19 170
Sarcopenia as a risk factor for falls in elderly individuals: Results from the ilSIRENTE study 155
Midarm muscle circumference, physical performance and mortality: results from the aging and longevity study in the Sirente geographic area (ilSIRENTE study). 149
Nonsteroidal Anti-Inflammatory Drug (NSAID) Use and Sarcopenia in Older People: Results From the ilSIRENTE Study 149
"The Memory of Beauty" Survives Alzheimer's Disease (but Cannot Help Memory) 148
Gemelli decision tree Algorithm to Predict the need for home monitoring or hospitalization of confirmed and unconfirmed COVID-19 patients (GAP-Covid19): preliminary results from a retrospective cohort study 147
Prevalence of Impulsive-Compulsive Symptoms in Elderly Parkinson's Disease Patients: A Case-Control Study 146
Association of anorexia with sarcopenia in a community-dwelling elderly population: results from the ilSIRENTE study 145
Venous thromboembolism among elderly patients treated with atypical and conventional antipsychotic agents. 142
All-cause mortality associated with atypical and conventional antipsychotics among nursing home residents with dementia: a retrospective cohort study 139
Anorexia, physical function, and incident disability among the frail elderly population: results from the ilSIRENTE study 137
Effect of Proinflammatory Gene Polymorphisms on the Risk of Alzheimer's Disease. 137
The “development of metabolic and functional markers of dementia in older people” (ODINO) study: Rationale, design and methods 132
Heart failure and adverse drug reactions among hospitalized older adults. 127
Platelets and Neurodegenerative Diseases: Current Knowledge and Future Perspectives 125
Bone mineral density in adults with Down syndrome 123
Omega-3 polyunsaturated fatty acids and depression: a review of the evidence 122
Sarcopenia and mortality risk in frail older persons aged 80 years and older: results from ilSIRENTE study 122
What is semantic in semantic dementia? The decay of knowledge of physical entities but not of verbs, numbers and body parts 122
Effects of anorexia on mortality among older adults receiving home care: an observation study 120
The Geriatrician: The Frontline Specialist in the Treatment of COVID-19 Patients 120
Interaction between GSTM1 genotype and IL-6 on mortality in older adults: results from the ilSIRENTE study 119
Calf circumference, frailty and physical performance among older adults living in the community 119
Venous thromboembolism among elderly patients treated with atypical and conventional antipsychotic agents 118
The new metabolic treatments for sarcopenia 118
Conventional or atypical antipsychotics and the risk of hospitalization for ventricular arrhythmias and cardiac arrest 117
Impact of inappropriate drug use among hospitalized older adults 115
Assessment of nursing home residents in Europe: the Services and Health for Elderly in Long TERm care (SHELTER) study 115
Prevalence of Obsessive-Compulsive Symptoms in Elderly Parkinson Disease Patients: A Case-Control Study 114
Herbal Medications in Cardiovascular Medicine 114
Interaction between GSTM1 genotype and IL-6 on mortality in older adults: results from the ilSIRENTE study. 112
Polypharmacy in nursing home in Europe: results from the SHELTER study 111
What about the caregiver? A journey into Parkinson’s disease following the burden tracks 111
Second and third generation assessment instruments: the birth of standardization in geriatric care 110
Managing antipsychotic medications in schizophrenia: comprehensive assessment and personalized care to improve clinical outcomes and reduce costs 107
Cognitive Decline in Older Long-Term Survivors From Non-Hodgkin Lymphoma: A Multicenter Cross-Sectional Study 106
Practice differences between the United States and Canada 105
Prevalence of Obsessive-Compulsive Symptoms in Elderly Parkinson Disease Patients: A Case-Control Study 104
Prevalence of dyslipidemia and hypercholesterolemia awareness: results from the Lookup 7+ online project 104
Polypharmacy in nursing home residents with severe cognitive impairment: Results from the SHELTER Study 101
Distress of caregivers of older adults receiving home care in European countries: results from the AgeD in HOme Care Study 99
Gender may be related to the side of the motorsyndrome and cognition in idiopathic Parkinson’sdisease 99
Association between frailty and ischemic heart disease: a systematic review and meta-analysis 99
Association between pain and depression among older adults in Europe: results from the Aged in Home Care (AdHOC) project: a cross-sectional study 98
Cerebrovascular events among elderly nursing home patients treated with conventional or atypical antipsychotics 97
Association of Delirium and Depression with Respiratory and Outcome Measures in COVID-19 Inpatients 94
Polypharmacy in nursing home residents with severe cognitive impairment: results from the SHELTER Study 94
Antipsychotic drug interactions and mortality among nursing home residents with cognitive impairment 93
JAMA PATIENT PAGE. Herbal Medications 93
The usefulness of anthropometric measures 92
Polypharmacy and mortality among nursing home residents with advanced cognitive impairment: results from the SHELTER study 90
Association between Older Age and Psychiatric Symptoms in a Population of Hospitalized Patients with COVID-19 89
Conventional and atypical antipsychotics and the risk of hospitalization for ventricular arrhythmias or cardiac arrest 87
Inappropriate drugs in elderly patients with severe cognitive impairment: results from the shelter study 87
Physical Restraint and Antipsychotic Medication Use Among Nursing Home Residents With Dementia 86
Prevalence and correlates of cardiovascular medication use among nursing home residents with ischemic heart disease: results from the SHELTER study 86
The use of atypical antipsychotics in nursing homes 85
What about the caregiver? A journey into Parkinson's disease following the burden tracks 84
Sarcopenia and mortality risk in frail older persons aged 80 years and older: results from ilSIRENTE study 84
Interleukin-6, C-reactive protein, and tumor necrosis factor-alpha as predictors of mortality in frail, community-living elderly individuals. 83
The Geriatrician: The Frontline Specialist in the Treatment of COVID-19 Patients 81
Frailty modifies the effect of polypharmacy and multimorbidity on the risk of death among nursing home residents: Results from the SHELTER study 81
Polypharmacy in nursing home residents with severe cognitive impairment: results from the SHELTER Study 81
Physical Restraint and Antipsychotic Medication Use Among Nursing Home Residents With Dementia 79
Balancing the risks and benefits of antipsychotic medications for symptom management in older patients with cancer 79
Association of Body Fat With Health-Related Quality of Life and Depression in Nonagenarians: The Mugello Study. 78
Pilot randomised experimental study evaluating isopropyl alcohol and UVC radiation in the disinfection of healthcare workers' smartphones 78
Gender may be related to the side of the motor syndrome and cognition in idiopathic Parkinson's disease 77
Pain in European long-term care facilities: cross-national study in Finland, Italy and The Netherlands 76
Association between frailty and ischemic heart disease: a systematic review and meta-analysis 74
Comorbidity patterns in institutionalized older adults affected by dementia 73
Relationship between frailty and drug use among nursing homes residents: results from the SHELTER study 73
Conventional or atypical antipsychotics and the risk of femur fracture among elderly patients: results of a case-control study 73
Gender may be related to the side of the motor syndrome and cognition in idiopathic Parkinson's disease 72
All-cause mortality and antipsychotic use among elderly persons with high baseline cardiovascular and cerebrovascular risk: a multi-center retrospective cohort study in Italy 71
Use of antipsychotic drugs among residents with dementia in European long-term care facilities: results from the SHELTER study 70
Use of antidepressant medications among older adults in European long-term care facilities: a cross-sectional analysis from the SHELTER study 70
Fatal neuroleptic malignant syndrome in a previously long-term user of clozapine following its reintroduction in combination with paroxetine 65
Mild cognitive impairment and microbiota: what is known and future perspectives 63
Prevalence and management of dysphagia in nursing home residents in Europe and Israel: the SHELTER Project 62
Adverse events among nursing home residents with Alzheimer's disease and psychosis. 62
Optimising the care for older persons with complex chronic conditions in home care and nursing homes: design and protocol of I-CARE4OLD, an observational study using real-world data 58
A retrospective, longitudinal study of factors associated with new antipsychotic medication use among recently admitted long-term care residents 58
Antipsychotics and the risk of venous thromboembolism 57
Applying the FAIR4Health Solution to Identify Multimorbidity Patterns and Their Association with Mortality through a Frequent Pattern Growth Association Algorithm 57
Prognostic Interplay of Functional Status and Multimorbidity Among Older Patients Discharged From Hospital 53
The “development of metabolic and functional markers of dementia in older people” (ODINO) study: Rationale, design and methods 49
A Longitudinal Treatment Effect Analysis of Antipsychotics on Behavior of Residents in Long-Term Care 49
Managing antipsychotic medications in schizophrenia: Comprehensive assessment and personalized care to improve clinical outcomes and reduce costs 48
The Association of Anticholinergic Drugs and Delirium in Nursing Home Patients With Dementia: Results From the SHELTER Study 47
JAMA PATIENT PAGE. Herbal Medications 46
Neuropsychiatric Symptoms in Elderly With Dementia During COVID-19 Pandemic: Definition, Treatment, and Future Directions 46
Technology-Assisted Cognitive Motor Dual-Task Rehabilitation in Chronic Age-Related Conditions: Systematic Review 43
Totale 9.571
Categoria #
all - tutte 42.740
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 42.740


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021346 0 0 0 0 0 42 85 17 65 23 87 27
2021/2022621 47 60 27 37 39 18 13 130 26 29 75 120
2022/20231.379 168 187 122 178 92 183 64 124 172 25 45 19
2023/2024853 35 223 33 107 31 83 36 33 18 34 79 141
2024/20251.730 43 50 129 49 146 56 56 78 273 189 367 294
2025/20262.382 685 139 251 491 776 40 0 0 0 0 0 0
Totale 9.571